{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:50:05Z","timestamp":1785455405182,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1177\/1933719115570900","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T03:08:22Z","timestamp":1423451302000},"page":"942-947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome"],"prefix":"10.1007","volume":"22","author":[{"given":"Mete","family":"Ergenoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkim Gulsah Sahingoz","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Yeniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oytun","family":"Erbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altug","family":"Yavasoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Taskiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedim","family":"Karadadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"22080942_CR1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.52.1.401","volume":"52","author":"A Dunaif","year":"2001","unstructured":"Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med. 2001;52:401\u2013419.","journal-title":"Annu Rev Med"},{"issue":"6","key":"22080942_CR2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","volume":"83","author":"WY Chang","year":"2005","unstructured":"Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005;83(6):1717\u20131723.","journal-title":"Fertil Steril"},{"issue":"4","key":"22080942_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347\u2013363.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"22080942_CR4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","volume":"12","author":"CM Boomsma","year":"2006","unstructured":"Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673\u2013683.","journal-title":"Hum Reprod Update"},{"key":"22080942_CR5","doi-asserted-by":"crossref","first-page":"d6309","DOI":"10.1136\/bmj.d6309","volume":"343","author":"N Roos","year":"2011","unstructured":"Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ. 2011;343:d6309.","journal-title":"BMJ"},{"issue":"1","key":"22080942_CR6","doi-asserted-by":"crossref","first-page":"77.e1","DOI":"10.1016\/j.ajog.2006.07.046","volume":"196","author":"JG Wang","year":"2007","unstructured":"Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA. M\u00fcllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am J Obstet Gynecol. 2007;196(1):77.e1\u2013e5.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"22080942_CR7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","volume":"134","author":"A Somunkiran","year":"2007","unstructured":"Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-M\u00fcllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2007;134(2):196\u2013201.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"22080942_CR8","first-page":"3836","volume":"84","author":"ER De Meyts","year":"1999","unstructured":"De Meyts ER, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab. 1999;84(10):3836\u20133844.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"22080942_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","volume":"77","author":"A de Vet","year":"2002","unstructured":"de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357\u2013362.","journal-title":"Fertil Steril"},{"issue":"9","key":"22080942_CR10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2008.08.002","volume":"19","author":"FJ Broekmans","year":"2008","unstructured":"Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19(9):340\u2013347.","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"22080942_CR11","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/humrep\/des213","volume":"27","author":"TB Eilertsen","year":"2012","unstructured":"Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod. 2012;27(8):2494\u20132502.","journal-title":"Hum Reprod"},{"issue":"8","key":"22080942_CR12","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","volume":"98","author":"S Iliodromiti","year":"2013","unstructured":"Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab. 2013;98(8):3332\u20133340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"22080942_CR13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0015-0282(00)00695-6","volume":"74","author":"TL Loucks","year":"2000","unstructured":"Loucks TL, Talbott EO, McHugh KP, Keelan M, Berga SL, Guzick DS. Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? Fertil Steril. 2000;74(3):547\u2013552.","journal-title":"Fertil Steril"},{"issue":"4","key":"22080942_CR14","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","volume":"174","author":"DS Guzick","year":"1996","unstructured":"Guzick DS, Talbott EO, Sutton-Tyrrell K, Herzog HC, Kuller LH, Wolfson SK. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol. 1996;174(4):1224\u20131229.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"22080942_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","volume":"34","author":"T Sabuncu","year":"2001","unstructured":"Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34(5):407\u2013413.","journal-title":"Clin Biochem"},{"key":"22080942_CR16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2013.11.011","volume":"173","author":"Y Shi","year":"2014","unstructured":"Shi Y, Cui Y, Sun X, et al. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors. Eur J Obstet Gynecol Reprod Biol. 2014;173:66\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"22080942_CR17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.2005-1696","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(1):336\u2013340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"22080942_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"W Dr\u00f6ge","year":"2002","unstructured":"Dr\u00f6ge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82(1):47\u201395.","journal-title":"Physiol Rev"},{"issue":"4","key":"22080942_CR19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1471-4159.1996.67041375.x","volume":"67","author":"R Dringen","year":"1996","unstructured":"Dringen R, Hamprecht B. Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J Neurochem. 1996;67(4):1375\u20131382.","journal-title":"J Neurochem"},{"issue":"6","key":"22080942_CR20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493\u2013506.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"22080942_CR21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrm1616","volume":"6","author":"L Bordone","year":"2005","unstructured":"Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol. 2005;6(4):298\u2013305.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5297","key":"22080942_CR22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"275","author":"M Jang","year":"1997","unstructured":"Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275(5297):218\u2013220.","journal-title":"Science"},{"issue":"3-4","key":"22080942_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cbpc.2005.11.002","volume":"142","author":"R Rodrigo","year":"2006","unstructured":"Rodrigo R, Bosco C. Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review. Comp Biochem Physiol C Toxicol Pharmacol. 2006;142(3\u20134):317\u2013327.","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"22080942_CR24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2010.05843.x","volume":"1215","author":"G Petrovski","year":"2011","unstructured":"Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci. 2011;1215:22\u201333.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"22080942_CR25","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","volume":"148","author":"L Manner\u00e5s","year":"2007","unstructured":"Manner\u00e5s L, Cajander S, Holm\u00e4ng A, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 2007;148(8):3781\u20133791.","journal-title":"Endocrinology"},{"issue":"6","key":"22080942_CR26","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","volume":"88","author":"M Fassnacht","year":"2003","unstructured":"Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W. Beyond adrenal and ovarian androgen generation: increased peripheral 5\u03b1-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(6):2760\u20132766.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"22080942_CR27","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","volume":"88","author":"ME Silfen","year":"2003","unstructured":"Silfen ME, Denburg MR, Manibo AM, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between non-obese and obese adolescents. J Clin Endocrinol Metab. 2003;88(10):4682\u20134688.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"22080942_CR28","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/1933719113483014","volume":"20","author":"AM Ergeno\u011flu","year":"2013","unstructured":"Ergeno\u011flu AM, Yeniel A\u00d6, Erba\u015f O, et al. Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats. Reprod Sci. 2013;20(10):1230\u20131236.","journal-title":"Reprod Sci"},{"issue":"1-2","key":"22080942_CR29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2005.12.035","volume":"245","author":"S Busquets","year":"2007","unstructured":"Busquets S, Ametller E, Fuster G, et al. Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Lett. 2007;245(1\u20132):144\u2013148.","journal-title":"Cancer Lett"},{"issue":"1","key":"22080942_CR30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70\u201377.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"22080942_CR31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/clinchem\/34.3.497","volume":"34","author":"Y Sun","year":"1988","unstructured":"Sun Y, Oberley L, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497\u2013500.","journal-title":"Clin Chem"},{"key":"22080942_CR32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121\u2013126.","journal-title":"Methods Enzymol"},{"key":"22080942_CR33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u2013254.","journal-title":"Anal Biochem"},{"key":"22080942_CR34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.52.1.401","volume":"52","author":"A Dunaif","year":"2001","unstructured":"Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med. 2001;52:401\u2013419.","journal-title":"Annu Rev Med"},{"issue":"1","key":"22080942_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u201347.","journal-title":"Hum Reprod"},{"issue":"12","key":"22080942_CR36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/aogs.12247","volume":"92","author":"S Sahmay","year":"2013","unstructured":"Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H. Elevated serum levels of anti-M\u00fcllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2013;92(12):1369\u20131374.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"22080942_CR37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/molehr\/gaq002","volume":"16","author":"DH Wong","year":"2010","unstructured":"Wong DH, Villanueva JA, Cress AB, Duleba AJ. Effects of resveratrol on proliferation and apoptosis in rat ovarian thecainterstitial cells. Mol Hum Reprod. 2010;16(4):251\u2013259.","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"22080942_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1757-2215-7-21","volume":"7","author":"I Ortega","year":"2014","unstructured":"Ortega I, Villanueva JA, Wong DH, et al. Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis. J Ovarian Res. 2014;7(1):21.","journal-title":"J Ovarian Res"},{"issue":"3","key":"22080942_CR39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/09513590400007309","volume":"19","author":"B Berker","year":"2004","unstructured":"Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy. Gynecol Endocrinol. 2004;19(3):125\u2013133.","journal-title":"Gynecol Endocrinol"},{"key":"22080942_CR40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2407-10-238","volume":"10","author":"J Vanamala","year":"2010","unstructured":"Vanamala J, Reddivari L, Radhakrishnan S, Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R\/Wnt and activation of p53 signaling pathways. BMC Cancer. 2010;10:238.","journal-title":"BMC Cancer"},{"issue":"2","key":"22080942_CR41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.atherosclerosis.2008.09.010","volume":"204","author":"S Rajendran","year":"2009","unstructured":"Rajendran S, Willoughby SR, Chan WP, et al. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis. 2009;204(2):509\u2013514.","journal-title":"Atherosclerosis"},{"issue":"10","key":"22080942_CR42","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1210\/jc.2011-0651","volume":"96","author":"VM Victor","year":"2011","unstructured":"Victor VM, Rocha M, Ba\u00f1uls C, et al. Induction of oxidative stress and human leukocyte\/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2011;96(10):3115\u20133122.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"22080942_CR43","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3945\/an.113.005264","volume":"5","author":"GE Bigford","year":"2014","unstructured":"Bigford GE, Del Rossi G. Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders. Adv Nutr. 2014;5(4):394\u2013403.","journal-title":"Adv Nutr"},{"issue":"1-2","key":"22080942_CR44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-8981(95)06069-P","volume":"237","author":"DM Goldberg","year":"1995","unstructured":"Goldberg DM, Hahn SE, Parkes JG. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta. 1995;237(1\u20132):155\u2013187.","journal-title":"Clin Chim Acta"},{"key":"22080942_CR45","first-page":"S0925","volume":"pii","author":"CK Singh","year":"2014","unstructured":"Singh CK, Ndiaye MA, Ahmad N. Resveratrol and cancer: challenges for clinical translation[published online November 8, 2014.]. Biochim Biophys Acta. 2014. pii: S0925-4439(14)00334-2.","journal-title":"Biochim Biophys Acta"},{"issue":"1-3","key":"22080942_CR46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2008.06.067","volume":"591","author":"JA Rubiolo","year":"2008","unstructured":"Rubiolo JA, Mithieux G, Vega FV. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol. 2008;591(1\u20133):66\u201372.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"22080942_CR47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/727072831","volume":"43","author":"M L\u00f3pez-V\u00e9lez","year":"2003","unstructured":"L\u00f3pez-V\u00e9lez M, Mart\u00ednez-Mart\u00ednez F, Del Valle-Ribes C. The study of phenolic compounds as natural antioxidants in wine. Crit Rev Food Sci Nutr. 2003;43(3):233\u2013244.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"22080942_CR48","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1124\/mol.109.058479","volume":"76","author":"SM Shin","year":"2009","unstructured":"Shin SM, Cho IJ, Kim SG. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinasemediated glycogen synthase kinase-3beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol Pharmacol. 2009;76(4):884\u2013895.","journal-title":"Mol Pharmacol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115570900.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719115570900","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719115570900\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719115570900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115570900.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:36:26Z","timestamp":1656812186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719115570900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["22080942"],"URL":"https:\/\/doi.org\/10.1177\/1933719115570900","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"2 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}